We are live on ! Find out more
CFM

Catalyst Funds Management Portfolio holdings

AUM $591M
1-Year Est. Return 71.09%
This Fund
S&P 500
This Quarter Est. Return
+11.2%
1 Year Est. Return
+71.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$591M
AUM Growth
+$160M
Cap. Flow
+$155M
Cap. Flow %
26.27%
Top 10 Hldgs %
18.1%
Holding
732
New
402
Increased
110
Reduced
53
Closed
148

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$11.5M
2
ARM icon
Arm
ARM
+$10.9M
3
AZN icon
AstraZeneca
AZN
+$10M
4
CSCO icon
Cisco
CSCO
+$8.29M
5
ABBV icon
AbbVie
ABBV
+$7.72M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$24.5M
2
NVDA icon
NVIDIA
NVDA
+$16.4M
3
RVMD icon
Revolution Medicines
RVMD
+$15.9M
4
RIO icon
Rio Tinto
RIO
+$11.5M
5
WMT icon
Walmart Inc
WMT
+$9.5M

Sector Composition

Rank Sector Weight
1 Technology 22.62%
2 Industrials 14.98%
3 Healthcare 13.14%
4 Financials 10.95%
5 Materials 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GALT icon
526
Galectin Therapeutics
GALT
$230M
$62.8K 0.01%
+22,500
New +$68.4K
DTI icon
527
Drilling Tools International
DTI
$79.8M
$61.9K 0.01%
+14,300
New +$51.5K
CRBU icon
528
Caribou Biosciences
CRBU
$165M
$61.2K 0.01%
+32,200
New +$55.3K
OGN icon
529
Organon & Co
OGN
$3.55B
$59.9K 0.01%
+10,000
New +$75.2K
SND icon
530
Smart Sand
SND
$207M
$59.4K 0.01%
+11,600
New +$52.3K
SABS icon
531
SAB Biotherapeutics
SABS
$274M
$57.8K 0.01%
+15,100
New +$60.2K
CABA icon
532
Cabaletta Bio
CABA
$448M
$57.3K 0.01%
+21,300
New +$59.1K
EMPD
533
Empery Digital
EMPD
$95.9M
$56.7K 0.01%
+13,400
New +$58K
BNC
534
CEA Industries
BNC
$121M
$56.6K 0.01%
+19,400
New +$85.5K
NWL icon
535
Newell Brands
NWL
$2.29B
$55.5K 0.01%
+16,169
New +$67.9K
PALI icon
536
Palisade Bio
PALI
$330M
$55K 0.01%
+31,400
New +$57.1K
ACHV icon
537
Achieve Life Sciences
ACHV
$648M
$52.9K 0.01%
+18,000
New +$79.9K
GNLX icon
538
Genelux
GNLX
$133M
$52.8K 0.01%
+21,824
New +$59.5K
MBOT icon
539
Microbot Medical
MBOT
$119M
$52.8K 0.01%
+21,900
New +$48.9K
MGNX icon
540
MacroGenics
MGNX
$273M
$51.2K 0.01%
+17,700
New +$37.8K
CLVT icon
541
Clarivate
CLVT
$1.27B
$48.3K 0.01%
+19,100
New +$48.9K
PLBY icon
542
Playboy Inc
PLBY
$147M
$48.2K 0.01%
+31,700
New +$57.9K
RPID icon
543
Rapid Micro Biosystems
RPID
$103M
$48.1K 0.01%
+21,200
New +$77.6K
SERA icon
544
Sera Prognostics
SERA
$81.5M
$47.8K 0.01%
+23,564
New +$60.7K
VENU
545
Venu Holding Corp
VENU
$141M
$46.7K 0.01%
+14,100
New +$81.3K
LODE icon
546
Comstock
LODE
$300M
$46.1K 0.01%
+15,100
New +$49.4K
NUVB icon
547
Nuvation Bio
NUVB
$2.28B
$45.5K 0.01%
+10,600
New +$59.1K
TONX
548
TON Strategy Co
TONX
$193M
$45.2K 0.01%
+18,300
New +$46K
SPRU icon
549
Spruce Power Holding Corp
SPRU
$41.9M
$44.3K 0.01%
+10,800
New +$50K
CRGO icon
550
Freightos
CRGO
$62.5M
$43.1K 0.01%
+26,300
New +$49.8K
20 21
22
23 24

Similar funds

BBL
Beck Bode LLC Dedham, Massachusetts $591M AUM 37.12% 1-Year Est. Return
BA
Bellwether Advisors Lincoln, Nebraska $590M AUM 35.66% 1-Year Est. Return
DPRC
Deer Park Road Corp Steamboat Springs, Colorado $591M AUM 27.7% 1-Year Est. Return
FL
Fourthstone LLC St Louis, Missouri $590M AUM 29.58% 1-Year Est. Return
MW
Maia Wealth Denver, Colorado $591M AUM 16.31% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
LBIM
Land & Buildings Investment Management Stamford, Connecticut $591M AUM 10.19% 1-Year Est. Return
MPW
MA Private Wealth San Carlos, California $591M AUM 16.05% 1-Year Est. Return

Catalyst Funds Management's Q1 2026 Portfolio in Review

As of Q1 2026, Catalyst Funds Management held 732 positions worth $591M, up 37% from $431M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Catalyst Funds Management deployed $155M of net new capital in Q1 2026, opening 402 new positions and adding to 110 existing holdings. Its largest new stake was Medline Inc: 259,595 shares worth $11.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Broadcom, an estimated $24.5M trimmed.

  • Catalyst Funds Management's largest Q1 2026 buy was Medline Inc: 259,595 shares worth $11.6M.
  • Catalyst Funds Management added most to AstraZeneca in Q1 2026, an estimated $10M increase.
  • Catalyst Funds Management's biggest Q1 2026 reduction was Broadcom, cutting an estimated $24.5M.
  • Catalyst Funds Management fully exited News Corp Class B in Q1 2026, selling an estimated $5.22M.
  • Catalyst Funds Management's ten largest holdings make up 18% of its $591M portfolio in Q1 2026.
  • Catalyst Funds Management opened 402 new positions and closed 148 in Q1 2026.
  • Catalyst Funds Management's portfolio value rose 37% quarter-over-quarter to $591M.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.